ABOUT RITUXIMAB

Truqap is a kinase inhibitor that actually works by blocking pathways that assist the most cancers cells survive and develop, so minimizes cancer growth. Truqap is from a category of medicines named an AKT inhibitor. Truqap acquired FDA approval on November seventeen, 2023, immediately after beneficial results within the CAPItello-291 Period III de